CD47 and neoplasm: Another study conducted in non-small cell lung cancer (NSCLC) tumor tissues and cell lines demonstrated that CD47 is overexpressed in these tumors and is significantly associated with clinical staging, lymph node metastases, and distant metastases (Zhao et al. 2016).